InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Kelly Scott A., Président. Director active across 1 company, notably CytoDyn Inc.. Aggregated, 14 disclosures have been logged. Activity tracked since 6 August 2021. The latest transaction was filed on 30 November 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kelly Scott A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
16,927 shares0Common StockSEC:0001104659-22-123365:0
15,234 shares0Common StockSEC:0001104659-22-119979:0
17,922 shares0Common StockSEC:0001104659-22-114101:0
13,849 shares0Common StockSEC:0001104659-22-109687:0
18,793 shares0Common StockSEC:0001104659-22-105980:0
9,457 shares0Common StockSEC:0001104659-22-101258:0
11,094 shares0Common StockSEC:0001104659-22-097603:0
6,950 shares0Common StockSEC:0001104659-22-092174:0
7,492 shares0Common StockSEC:0001104659-22-086117:0
13,112 shares0Common StockSEC:0001104659-22-080836:0
13,736 shares0Common StockSEC:0001104659-22-077432:0
14,423 shares0Common StockSEC:0001104659-22-073001:0
15,592 shares0Common StockSEC:0001104659-22-069307:0
40,661 shares0Common stockSEC:0000899243-21-032395:0
14 of 14 declarations
About Kelly Scott A.
Kelly Scott A. is President and CMO of CytoDyn Inc. The declarant has 14 filings in total, and the sampled recent filings run from 2021-08-10 to 2022-11-30, with the modal transaction nature shown as Attribution.
